21 September 2024 : Clinical Research
Comparison of Remimazolam and Dexmedetomidine for Sedation in Awake Endotracheal Intubation in Scoliosis Surgery: A Retrospective Analysis
Lei Zhou1ABDEF*, Yu Huang2ABDEF, Rui Zhou3CDE, Siyuan Liu1ADEFDOI: 10.12659/MSM.944632
Med Sci Monit 2024; 30:e944632
Table 1 Characteristics of the study population.
| Parameters | Rem group | Dex group | Difference [95% CI] | P value |
|---|---|---|---|---|
| Male (n, %) | 36, 65.45 | 29, 67.44% | – | 0.836 |
| Age (years) | 30.98±8.38 | 32.70±7.45 | −1.72 [−4.993, 1.562] | 0.301 |
| Height (cm) | 152.13±7.81 | 150.47±6.62 | 1.66 [−1.29, 4.62] | 0.267 |
| Weight (kg) | 44.22±5.42 | 42.05±4.04 | 2.17 [0.21, 4.14] | 0.031 |
| BMI (kg/m) | 19.06±1.29 | 18.57±1.37 | 0.49 [−0.05, 1.02] | 0.074 |
| Mallampati grade | 0.836 | |||
| III (n, %) | 19, 34.55% | 17, 39.53% | – | |
| IV (n, %) | 36, 65.45% | 26, 60.47% | – | |
| BMI – body mass index; Rem – remimazolam; Dex – dexmedetomidine. | ||||






